PA
MDLN

Perceptive Advisors’s Medline Inc MDLN Stock Holding History

Perceptive Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.1M Hold
28,000
– – 0.02% 104
2026
Q1 		$1.25M Hold
28,000
– – 0.02% 88
2025
Q4 		$1.18M Buy
+28,000
New +$1.18M 0.02% 108

Other funds holding MDLN

CG
Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return
HFCIX
H&F Corporate Investors X San Francisco, California $2.8B AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
LPC
Lone Pine Capital Greenwich, Connecticut $16.4B AUM 99.7% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Perceptive Advisors's MDLN Position: Q2 2026 in Review

Perceptive Advisors held its Medline Inc (MDLN) position steady in Q2 2026 at 28,000 shares worth $1.1M. The position accounts for 0.02% of the portfolio, ranked #104.

Perceptive Advisors first reported a position in MDLN in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.25M in Q1 2026. 406 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • Perceptive Advisors held 28,000 shares of Medline Inc worth $1.1M as of Q2 2026.
  • Perceptive Advisors left its Medline Inc share count unchanged in Q2 2026.
  • Medline Inc made up 0.02% of Perceptive Advisors's portfolio in Q2 2026, its #104 holding.
  • Perceptive Advisors first reported a position in Medline Inc in Q4 2025 and has held it in 3 quarters since.
  • Perceptive Advisors's Medline Inc position peaked at $1.25M in Q1 2026.
  • 406 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on Perceptive Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.